comparison of two types of ventilation modes given through ventilator after treating with surfactant (medicine)needed to breath easily in premature infants
Not Applicable
- Conditions
- Health Condition 1: null- Neonatal Respiratory Distress Syndrome
- Registration Number
- CTRI/2018/01/011116
- Lead Sponsor
- Kasturba Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
will be selecting babies born at 28-32 weeks of gestation, presented with signs of respiratory distress (Tachypnea, flaring of nostrils, grunt and retractions)
Exclusion Criteria
1.Neonates requiring intubation in the delivery room.
2.Neonates with major congenital malformations.
3.Out born neonates.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Need for intubation and mechanical ventilation within the first 72 hours of life.Timepoint: 1.Need for intubation and mechanical ventilation within the first 72 hours of life.
- Secondary Outcome Measures
Name Time Method 1.Duration of non- invasive ventilation. <br/ ><br>2.Duration of invasive ventilation. <br/ ><br>3.Duration of supplemental oxygenation. <br/ ><br>4.Overall rate of intubation. <br/ ><br>5.Incidence of pneumothorax. <br/ ><br>Timepoint: at any point of time within NICU stay
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie surfactant therapy in neonatal respiratory distress syndrome?
How does nasal continuous positive pressure compare to nasal intermittent positive pressure ventilation in preterm infants with RDS?
What biomarkers predict successful surfactant administration in preterm infants with RDS?
What are the potential adverse events associated with nasal intermittent positive pressure ventilation in neonates?
Are there combination approaches involving surfactant therapy and ventilation modes for RDS management?